Log in

KIDS ORTHOPEDIATRICS CORP NASDAQ · United States

ORTHOPEDIATRICS CORP (KIDS) news

ORTHOPEDIATRICS CORP is a public biotech or pharmaceutical company listed on NASDAQ under the ticker KIDS, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest ORTHOPEDIATRICS CORP news

We have not published a story on ORTHOPEDIATRICS CORP yet. When there is news, it will appear here.

ORTHOPEDIATRICS CORP annual financials

LineFY2025FY2024
Research and development$9.1 million$11.0 million
Net income (loss)-$39.6 million-$37.8 million
Cash from operations-$4.9 million-$27.0 million
Cash and equivalents$19.6 million$43.8 million
Short-term investments$41.3 million$25.0 million

Latest balance sheet, Sep 30, 2026 (10-Q): cash and equivalents $17.1 million, plus short-term investments of $27.1 million, $44.2 million in all.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about ORTHOPEDIATRICS CORP

What is the ticker symbol of ORTHOPEDIATRICS CORP?

ORTHOPEDIATRICS CORP trades under the ticker KIDS on NASDAQ.

Where is ORTHOPEDIATRICS CORP listed?

ORTHOPEDIATRICS CORP is listed on NASDAQ.

Which country or territory is ORTHOPEDIATRICS CORP listed under?

Our directory records ORTHOPEDIATRICS CORP under United States.

Does aibio.space cover ORTHOPEDIATRICS CORP?

aibio.space lists ORTHOPEDIATRICS CORP among 2,820 public biotech companies and publishes its news here as stories appear.

Is ORTHOPEDIATRICS CORP profitable?

ORTHOPEDIATRICS CORP reported a net loss of $39.6 million for the fiscal year ended Dec 31, 2025, and used $4.9 million of cash in operations, per its annual report to the SEC.

How much does ORTHOPEDIATRICS CORP spend on research and development?

$9.1 million in the fiscal year ended Dec 31, 2025, per its annual report.

How much cash does ORTHOPEDIATRICS CORP have?

$44.2 million in cash and short-term investments at Sep 30, 2026, per its 10-Q.

Investor discussion: ORTHOPEDIATRICS CORP

Members talk about ORTHOPEDIATRICS CORP (KIDS). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:KIDS on TradingView.

Listing details

ORTHOPEDIATRICS CORP is a public biotech or pharmaceutical company listed on NASDAQ under the ticker KIDS, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
ORTHOPEDIATRICS CORP
Ticker
KIDS
Listing
NASDAQ
Country or territory
United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.